SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis. After adjustments, patients on SGLT2 inhibitors had a significantly reduced risk of progression to severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback